Skip to content
Open access

A stability-selected seven-gene transcriptomic panel in ulcerative colitis: Nested discovery and multicohort external evaluation.

Oct 2026 · Science in progress · Vol 109 4, pp. 368504261504475 · 0 citations · 17 references
Medicine

TL;DR

Repeated nested selection identified a seven-gene panel with consistent discrimination for active UC mucosal contrasts that mainly reflects active mucosal inflammation and requires prospective fixed-reference evaluation before clinical use.

Abstract

ObjectiveTo derive a stable mucosal transcriptomic panel for ulcerative colitis (UC) using leakage-resistant feature selection and to evaluate its performance across independent cohorts.MethodsThis secondary model-development study used human colonic mucosal transcriptomic data from GSE206171 (59 UC and 19 controls) for discovery. Twenty repetitions of five-fold outer cross-validation repeated differential-expression screening, candidate construction, feature ranking, scaling, and inner-CV tuning within each training fold. Genes selected in at least 70% of 100 outer folds defined the high-stability panel. Fixed coefficients were evaluated in GSE47908, GSE75214, GSE16879, and GSE243625. Secondary analyses examined published and inflammatory comparators, disease activity, immune enrichment, and donor-level SCP259 expression.ResultsThe fully nested pipeline yielded a mean AUC of 0.832 (SD 0.052; repeat-level 2.5th-97.5th percentiles 0.741-0.898). Seven genes met the 70% stability threshold: CASP1, SAA1, LCN2, DUOX2, LPCAT3, IDO1, and DEFA6. AUCs were 0.944-0.971 for disease or activity contrasts in GSE47908 and GSE75214. In GSE243625, participant-aware AUCs were 0.951 for inflamed UC mucosa versus healthy controls and 0.964 for paired inflamed versus macroscopically non-inflamed UC mucosa, but 0.529 for non-inflamed UC mucosa versus healthy controls; all 15 paired participants had higher scores in inflamed mucosa (P = 6.10 × 10-5). Baseline infliximab-response discrimination was poor (AUC 0.469). No AUC difference versus inflammatory comparators or three published UC signatures remained significant after multiple-testing correction in independent-sample comparisons. The panel-Mayo correlation (rho=0.714) was weaker than that for CXCL8 (rho=0.791).ConclusionsRepeated nested selection identified a seven-gene panel with consistent discrimination for active UC mucosal contrasts. Near-chance separation of macroscopically non-inflamed UC from healthy mucosa and the negative treatment-response result indicate that the score mainly reflects active mucosal inflammation and requires prospective fixed-reference evaluation before clinical use.

Read PDF

Similar papers

Open access Nov 2026

A mucosal barrier injury related six gene transcriptomic signature associated with ulcerative colitis using machine learning and public transcriptomic data

Ulcerative colitis (UC) is characterized by epithelial barrier disruption, mucosal immune activation, and sustained intestinal inflammation. We developed a biologically interpretable public-transcriptomic signature using Gene Expression Omnibus datasets GSE75214, GSE38713, and GSE92415. A literature-curated panel of 35...

Sen He, Ping-Liang Sun, X. Duan · 0 citations
Open access Nov 2026

Integrative transcriptomic and single-nucleus analyses identify microbiota–metabolite-associated immune signatures of fibrosis severity in MASLD

Objective To identify microbiota–metabolite-associated immune features associated with fibrosis severity and evaluate their cross-cohort expression, discrimination and cellular context in human liver. Methods Discovery used 206 NAFLD cases from GSE135251, comparing F0–F2 with F3–F4. Human gutMGene host genes were inter...

Zhi-Yun Liu, Jing Feng, Wen-Qiao Lu et al. · 0 citations
Open access Oct 2026

Cross-Platform External Validation of a Locked 12-Gene Prognostic Panel in Lung Adenocarcinoma Benchmarked Against Pathological Stage

Background/Objectives: A prognostic gene panel is clinically useful only if its risk ranking survives transfer across measurement platforms and adds information to pathological stage. We evaluated the cross-platform transportability of a 12-gene panel selected in TCGA-LUAD and fixed before external scoring, separating...

Faris A. Alrumaihi · 0 citations
Open access Oct 2026

Machine learning-derived R-loop-related diagnostic signature for psoriasis: a multi-cohort and single-cell validation study

Background Psoriasis is a chronic inflammatory skin disease characterized by dysregulated immune responses and keratinocyte (KC) hyperproliferation. Although therapeutic strategies have advanced considerably, achieving durable long-term remission remains challenging. R-loops are three-stranded nucleic acid structures i...

Ye-Qi Feng, Le-Bin Song, Xiao-Zheng Jiang et al. · 0 citations
Open access Nov 2026

Identification of claudin-3 as a candidate biomarker associated with gastric precancerous lesions: a multi-algorithm transcriptomic study with clinical protein-level validation

Abstract Objectives This study aimed to identify transcriptomic biomarkers for gastric low-grade intraepithelial neoplasia (LGIN), validate the lead candidate at the protein level in clinical LGIN biopsy specimens, and preliminarily evaluate its expression in intestinal metaplasia (IM). Methods Differentially expressed...

Qing-Qing Zhang, Tai Zhang, Di Wu et al. · 0 citations
Open access Nov 2026

Feature-Selection Stability and Functional Characterization of Sepsis-Related Transcriptomic Candidates Across Heterogeneous Cohorts

Sepsis-related transcriptomic signatures may differ across tissues and clinical settings, complicating their reproducibility and biological interpretation. We analyzed three public human microarray datasets spanning blood and skeletal muscle (GSE12624, GSE13205, and GSE69063; 26, 21, and 30 participants, respectively)...

Rossana O. Souza, W. Rodrigues, C. Miguel et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.